Two Onc Docs cover image

Esophageal and Gastrosophageal Junction (GEJ) Cancer 2025 UPDATE

Two Onc Docs

00:00

Key Trials Supporting Neoadjuvant Approaches

They summarize CROSS for chemoradiation and MAGIC/FLOT trials, noting FLOT4 adoption and the 2025 NEJM result favoring FLOT in adenocarcinoma.

Play episode from 08:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app